Effect of elafin in patients with acute postoperative complications following resection of esophageal cancer surgery (ECS).

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 21 Mar 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tiprelestat (Primary)
Indications Postoperative inflammation
Focus Registrational; Therapeutic Use
Acronyms POSTCOM
Sponsors tiakis Biotech

Most Recent Events

01 Sep 2022 According to a Tiakis Biotech media release, Proteo Biotech has changed its name to Tiakis Biotech.
18 Dec 2017 According to a Proteo Biotech media release, based on the European Medicines Agency advice letter, comapny is planning the trial
27 Mar 2015 New trial record

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight